Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Saudi Medical Journal. 2004; 25 (5): 638-641
in English | IMEMR | ID: emr-68708

ABSTRACT

To determine the precise radiologic findings in Wolfram syndrome [WFS] patients using objective techniques in order to better define the reference population for the clinical evaluation. Sixteen patients [6 males and 10 females] with WFS found in 4 families were included in this study. Fourteen patients with WFS-2 came from 3 families while 2 patients with WFS-1 from one family. All patients were studied at Jordan University Hospital, Amman, Jordan, from January 2001 through to January 2003 by definite radiologic techniques as part of a thorough clinical comprehensive assessment. These include intravenous urography, abdominal and pelvic ultrasonography, barium meal, upper gastrointestinal endoscopy and magnetic resonance imaging with and without contrast to the brain and the pituitary gl and s. Five of the female patients had a small uterus. Spina bifida was found in 7, hydronephrosis in 9 and hydroureter in 5 patients. Peptic ulcer was detected in 10 out of 14 available patients and helicobacter pylori in 7 out of 16 patients. Atrophy was detected in all brains, 9 brain stems, 12 cerebellums and 14 optic tracts of all patients. The size of the pituitary gl and s was variable. The particular radiologic assessment of patients with WFS proofed that, urinary tract dilatation was detected in WFS-1 and WFS-2 patients though all WFS-2 patients have no diabetes insipidus. Peptic ulcer was frequently higher in WFS-2 patients. No significant radiologic difference was found between patients with WFS-1 and WFS-2


Subject(s)
Humans , Male , Female , Wolfram Syndrome/classification , Magnetic Resonance Imaging , Urography , Hydronephrosis , Optic Atrophy , Cerebellum/pathology , Consanguinity
2.
Saudi Medical Journal. 2001; 22 (2): 104-109
in English | IMEMR | ID: emr-58239

ABSTRACT

Familial Mediterranean Fever is a genetic disorder frequently diagnosed among the Arabs. It is also prevalent among Jews, Armenians and Turks. The clinical picture consists of febrile and painful attacks that differ in quality across patients and even within the same patient. There may be accompanying joint pain, chest pain, skin manifestations and other findings, and amyloidosis may occur in some patients as a complication. The primary treatment is Colchicine, which decreases the frequency of the attacks and prevents the occurrence of amyloidosis. The gene responsible for Familial Mediterranean Fever, MEFV, has been mapped and cloned and mutations were identified within its coding sequence. It encodes a protein that is expected to be a down regulator of inflammation. The spectrum of mutations in the Arabic population is partially studied. There are still several issues to be solved before we fully understand the disorder, and to enable us to confront it and decrease the morbidity and mortality inflicted by it


Subject(s)
Familial Mediterranean Fever/pathology , Familial Mediterranean Fever/drug therapy , Colchicine , Colchicine/administration & dosage , Familial Mediterranean Fever/genetics
SELECTION OF CITATIONS
SEARCH DETAIL